PTCE Top 200 · #34

Empagliflozin

Jardiance

Empagliflozin is the generic name for the brand-name drug Jardiance. It is a sglt2 inhibitor used to treat type 2 diabetes, HF, CKD. On the PTCE Top 200 drug list, Empagliflozin ranks #34 and is one of the most frequently tested endocrine/diabetes medications — commonly quizzed on its brand–generic pair, drug class, and key side effects.

Generic nameEmpagliflozin
Brand name(s)Jardiance
Drug classSGLT2 inhibitor
Class groupEndocrine/Diabetes
Common usetype 2 diabetes, HF, CKD
DEA scheduleUnscheduled
AvailabilityPrescription only (Rx)

What is Empagliflozin used for?

SGLT2 inhibitor for type 2 diabetes; also indicated to reduce cardiovascular death and hospitalization for heart failure in adults with heart failure, and to slow progression of chronic kidney disease in certain adults (product‑specific).

What drug class is Empagliflozin?

Empagliflozin is a SGLT2 inhibitor in the Endocrine/Diabetes group. Knowing the class is the fastest way to predict its uses, side effects, and the brand↔generic pairs the PTCE tests.

Common side effects of Empagliflozin

Major interactions

Is Empagliflozin a controlled substance?

No. Empagliflozin is not a federally controlled substance (it is unscheduled by the DEA).

How to remember Empagliflozin (PTCE mnemonic)

JARD-iance GUARDs the heart — empa-GLIFLOZIN is SGLT2: 'pee out glucose'. UTIs/yeast, dehydration, euglycemic DKA, Fournier's gangrene.
lightbulb
PTCE exam tip

The suffix -gliflozin = an SGLT2 inhibitor for type 2 diabetes; it lowers sugar by spilling glucose into the urine (watch for UTIs / genital infections).

Empagliflozin FAQ

What is the brand name for Empagliflozin?

The brand name for Empagliflozin is Jardiance.

What is Empagliflozin used for?

Empagliflozin is used to treat type 2 diabetes, HF, CKD. SGLT2 inhibitor for type 2 diabetes; also indicated to reduce cardiovascular death and hospitalization for heart failure in adults with heart failure, and to slow progression of chronic kidney disease in certain adults (product‑specific).

What drug class is Empagliflozin?

Empagliflozin is a SGLT2 inhibitor (Endocrine/Diabetes group).

Is Empagliflozin a controlled substance?

No. Empagliflozin is not a federally controlled substance (it is unscheduled by the DEA).

Related drugs in the Endocrine/Diabetes group

Drill Empagliflozin the way the PTCE asks it

RxReflex turns the Top 200 drugs into fast flashcard rounds, a guided Learn path, pharmacy math, and 40+ cheat sheets. Free to start.

Last reviewed June 25, 2026. Educational use only — not medical advice. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).